Constellation Pharmaceuticals Inc. (NASDAQ:CNST) went down by -1.05% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Biotechnology giant went up by $30.11 to trade ended Wednesday trading at $30.43. This is down from the $30.43 price recorded on Tuesday’s trading session. Thanks to this latest performance, CNST is closer to the higher price 52-week target of $75.00 and further from the lowest price target of $34.00. Its performance from the start of the year has also been negative, with CNST down by -36.09% year-to-date.
Constellation Pharmaceuticals Inc. (CNST) started the day trading at $30.1 and recorded an intraday high of $31.395. It also recorded an intraday low of $29.71 during Wednesday’s trading session. Constellation Pharmaceuticals Inc. is a very active stock that recorded a trading volume that is more than 24.04% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 749537, which is more than 24.04 of the total average daily trading volume of 569.34K.
Constellation Pharmaceuticals Inc. (NASDAQ:CNST) 2020 Performance Impressive
The increase in CNST’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of CNST currently stands at $59.49, which is higher than the current trading price of the stock by 49.39%. However, CNST’s current trading price is -401.0% lower than the 52-week low price of $6.01. In terms of trading volume, Constellation Pharmaceuticals Inc. currently experienced healthy participation during the last trading session. 749537 shares of Constellation Pharmaceuticals Inc. were traded on the stock exchange on Wednesday, which is more than 24.04% of the 569.34K average trading volume of the stock.
The performance of the stock has been positive over the past year. CNST’s performance over the past one year has seen it surge by 233.08%, while the stock has gone down by -34.00% in the last six months. The quarterly performance of CNST currently stands at -0.36%, and it is down by -13.18% in the last month. The only negative figure was from the weekly performance, which currently reads -5.99%. At the time of writing CNST’s report, the company has a total market cap of $1.50B, making it one of the largest publicly-traded companies in the world.Constellation Pharmaceuticals Inc. also has over 106 employees all over the world.
CNST Insider Activities
For Constellation Pharmaceuticals Inc., insiders hold 93.10% of all company shares. The insider transactions over the past six months are up by 37.40%. During that period, insiders bought 232,484 shares in 51 transactions. In that same period, insiders sold 162,736 of their shares in 40 transactions. After these transactions, insiders at Constellation Pharmaceuticals Inc. now hold 897.84k shares, which is over 99.53% of the total company stocks. Institutional investors currently hold a large chunk of the CNST shares, as they control 2.15% of the company’s total stock.
CNST Fundamental Analysis
For Constellation Pharmaceuticals Inc., the stock’s diluted earnings per share (EPS) stands at -2.50. In the coming year, analysts expect the EPS to be -2.87. The stock’s EPS growth this year is 11.70%, with analysts expecting almost a 1 growth in the earnings per share next week.
CNST Analysts Prediction
The H.C. Wainwright has a Buy rating for Constellation Pharmaceuticals Inc., predicting the stock price to stay between $50 and $75. and BMO Capital Markets reiterate their Market Perform position on the stock ($43 and $42).
H.C. Wainwright and H.C. Wainwright also believe that Constellation Pharmaceuticals Inc.’s stock is outperforming at the moment.
CNST Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of CNST currently stands at -13.26%, while the SMA50 is -19.46%. The biggest one is the SMA200, which is currently reading -3.51% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 37.43.